Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 21 filings·Updated 28 Sept 2026
Showing 10 of 21 filings.
28 Sept 20262 filings
AGM/EGMAGM

AGM 2026: two ordinary resolutions passed, including director rotation

AGM Details

  • Date and time: 28 September 2026 at 3:00 PM.
  • Mode: physical meeting at registered office; remote e-voting offered.

Resolutions and Outcomes

  • Resolution 1: Adoption of audited financial statements for year ended 31 March 2026 and reports.
  • Result: Passed with 68.08% in favour; 31.92% against.
  • Resolution 2: Re-appointment of Director by rotation.
  • Result: Passed with 67.26% in favour; 32.74% against.

Director Changes

  • Director changes: Re-appointment of director by rotation approved.
Filed 17:42View Source
AGM/EGMAGM

Shree Ganesh Biotech AGM 28 Sep 2026 approves financials and director re-appointment

AGM Details

  • AGM held on 28 September 2026 at 03:00 PM at the registered office, physical meeting.

Resolutions Passed

  • Adoption of audited financial statements for FY ended 31 March 2026 and reports approved.
  • Re-appointment of Aman Patel as director, retires by rotation, approved.

Voting and Outcome

  • All resolutions passed by the shareholders.

Director Changes

  • Aman Patel re-appointed; no other changes.
Filed 17:36View Source
17 Sept 20261 filing
Insider Trading / SASTClosure of Trading Window

Shree Ganesh Biotech (India) Ltd – Closure of Trading Window from 1 October 2026 till 48 (Forty-Eight) hours after the declaration of Unaudited Financial Results for the second quarter ended 30 September 2026

Shree Ganesh Biotech (India) Ltd – Closure of Trading Window from 1 October 2026 till 48 (Forty-Eight) hours after the declaration of Unaudited Financial Results for the second quarter ended 30 September 2026

Filed 17:25View Source
3 Sept 20263 filings
OthersReg. 34 (1) Annual Report

Shree Ganesh Biotech (India) Ltd FY2025-26: Revenue 644.27 lakh; PAT 37.76 lakh; no dividend declared

Financial performance

  • Total revenue for FY2025-26: Rs 644.27 lakh.
  • Total income includes Rs 497.05 lakh from operations and Rs 147.22 lakh other income.
  • Profit after tax: Rs 37.76 lakh; EPS 0.01.
  • Dividend for the year is not recommended.

Business overview

  • Engaged in production, processing and marketing of hybrid seeds.
  • Crops include corn, sunflower, cotton, paddy, grain sorghum, among others.
  • 100% revenue derives from seed-related activities.
  • No subsidiaries or joint ventures reported.

Dividend and capital allocation

  • Dividend not proposed for FY2025-26.
  • No amount proposed for transfer to reserves.
  • Authorized share capital Rs 40 crore; paid-up capital Rs 39.8624 crore.

Capital structure and liquidity

  • No borrowings outstanding as of 31 March 2026.
  • No deposits accepted; cash and cash equivalents Rs 0.97 lakh.
  • Current assets Rs 1,190.28 lakh; current liabilities Rs 16.95 lakh.
  • Equity share capital Rs 3,986.24 lakh; total equity Rs 6,363.34 lakh.

Governance and audit

  • Board has six directors; four are independent; Aman Patel is chair.
  • Key KM P: Kishan Naidu (CFO); Namita Acharya (Company Secretary).
  • Audit Committee: Sombir Singh (Chair), Amrutaben Solanki, Nimish Parmar.
  • Secretarial audit by Daksha Negi & Associates flagged SEBI LODR non-compliance and no internal auditor.
  • Internal controls deemed adequate; management reports to Audit Committee.

Management discussion and outlook

  • Management Discussion and Analysis notes the company is not currently active.
  • Working capital constraints hinder operations; cost-reduction measures underway.
  • Outlook depends on resuming operational activities.

Shareholding and market data

  • Promoters: Nil; Dematerialised shareholding is mandatory for trading.
  • Listing: BSE, Calcutta Stock Exchange, MSE India Limited; ISIN INE051N01026.
  • Total equity shares: 39,862,400 (Rs 3,986.24 lakh).
  • Major holders: Residents ~78.82%, NRIs 1.72%, FPIs 1.42%, HUF 1.25%, others.
  • Registrar: Satellite Corporate Services Private Limited.

Compliance and disclosures

  • POSH policy in place; no harassment complaints in 2025-26.
  • CSR not applicable; no related-party transactions reported.
  • No penalties or strictures from stock exchanges/SEBI in last three years.
Filed 11:57View Source
Corp. ActionBook Closure

Shree Ganesh Biotech books closure for AGM with EVoting window and record date.

Book closure details

  • Book closure: 21 Sep 2026 to 28 Sep 2026 (inclusive).
  • Purpose: for Annual General Meeting on 28 Sep 2026.
  • Record/cut-off date for voting: 21 Sep 2026.
  • Date of AGM: 28 Sep 2026.
  • Security: Equity shares.
  • EVoting window: 25 Sep 2026 09:00 to 27 Sep 2026 17:00.
Filed 11:31View Source
AGM/EGMAGM

Shree Ganesh Biotech sets 16th AGM for 28 Sept 2026 with two ordinary resolutions

AGM details

  • AGM date/time: 28 Sept 2026, 3:00 PM, physical at registered office.
  • Record date for voting: 21 Sept 2026.
  • Register closed: 21–28 Sept 2026 (inclusive).

Key resolutions

  • Ordinary: adopt audited financial statements for year ended 31 Mar 2026.
  • Ordinary: re-appoint Aman Patel (DIN 08483544) on rotation.

Voting/Outcome

  • Voting results not disclosed in this filing.

Director and remuneration

  • Aman Patel to be re-appointed; last drawn remuneration Nil.
Filed 11:26View Source
4 Aug 20262 filings
Company UpdateReg. 32 (1), (3) - Statement of Deviation & Variation

Statement confirms no deviation; no unutilised funds from past fund-raising proceeds.

Utilisation status of proceeds

  • Statement confirms no deviation; no funds remain unutilised from past fund-raising proceeds.
Filed 16:22View Source
ResultFinancial Results

Shree Ganesh Biotech posts Q1 FY27 unaudited loss of Rs 57.32 lacs on Rs 175.00 lacs total income

Financial highlights

  • Quarter ended 30-Jun-2026: Revenue from operations Rs 142.99 lacs.
  • Total income Rs 175.00 lacs; net loss Rs 57.32 lacs; EPS Rs -0.01.
  • Cost of materials consumed Rs 186.67 lacs; total expenses Rs 232.32 lacs.
  • Board approved unaudited standalone results; company has a single segment.
  • Statutory auditors conducted a limited review.
Filed 16:18View Source
7 Jul 20261 filing
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate confirms listing and dematerialisation actions under Regulation 74(5)

Dematerialisation/rematerialisation status

  • The securities in the certificates have been listed on the stock exchanges.
  • The certificates were mutilated and cancelled, with the depository's name substituted as registered owner.
  • No physical certificates were received for demat during the period.
Filed 18:00View Source
17 Mar 20261 filing
Insider Trading / SASTClosure of Trading Window

PFA

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 18:09View Source
Showing 10 of 21 filings